Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „expected“
Suchtreffer
Begriffe & Kennungen
Ketoconazole Esteve (previously Ketoconazole HRA) · 4.5 · 9 Medicinal product by Expected effect on drug levels Recommendation for co- therapeutic area administration T
Eintrag öffnenKetoconazole Esteve (previously Ketoconazole HRA) · 4.5 · Medicinal product by Expected effect on drug levels Recommendation for co- therapeutic area administration Ana
Eintrag öffnenKyprolis · 4.5 · Carfilzomib does not inhibit CYP1A2, 2B6, 2C8, 2C9, 2C19 and 2D6 in vitro and is therefore not expected to inf
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.8 · Classification of expected frequencies:
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.8 · Classification of expected frequencies:
Eintrag öffnenLeflunomide Zentiva (previously Leflunomide Winthrop) · 4.8 · Classification of expected frequencies:
Eintrag öffnenLeflunomide medac · 4.8 · Classification of expected frequencies: Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000
Eintrag öffnenLeflunomide ratiopharm · 4.8 · Classification of expected frequencies:
Eintrag öffnenLocametz · 4.5 · Based on in vitro interaction studies, gallium (68Ga) gozetotide is not expected to have any clinically signif
Eintrag öffnenLojuxta · 4.5 · Inducers of Medicines that induce CYP3A4 When co-administering CYP3A4 inducers CYP3A4 would be expected to inc
Eintrag öffnenLojuxta · 4.5 · Weak CYP3A4 inhibitors are When administered with atorvastatin, the expected to increase the exposure of dose
Eintrag öffnenLokelma · 4.5 · As sodium zirconium cyclosilicate is not absorbed or metabolised by the body, there are no expected effects of
Eintrag öffnenLopinavir/Ritonavir Viatris (previously Ritonavir Mylan) · 4.5 · Medicinal products that are contraindicated specifically due to the expected magnitude of interaction and pote
Eintrag öffnenLutathera · 4.8 · Due to the bone marrow toxicity of Lutathera, the most expected adverse reactions were related to haematologic
Eintrag öffnenM-M-RVaxPro · 4.5 · Administration of immune globulins concomitantly with M-M-RvaxPro may interfere with the expected immune respo
Eintrag öffnenMaviret · 4.5 · 33 HERBAL PRODUCTS St. John’s wort Not studied. Co-administration (Hypericum Expected: ↓ glecaprevir and ↓ pib
Eintrag öffnenMekinist · 4.5 · Based on clinical data, no loss of efficacy of hormonal contraceptives is expected when co- administered with
Eintrag öffnenMenQuadfi · 4.5 · It may be expected that in patients receiving immunosuppressive treatment an adequate immune response may not
Eintrag öffnenMicardis · 4.5 · Based on their pharmacological properties it can be expected that the following medicinal products may potenti
Eintrag öffnenMicardisPlus · 4.5 · 28 Based on their pharmacological properties it can be expected that the following medicinal products may pote
Eintrag öffnen